NCT03620019 2026-03-27Denosumab + PD-1 in Subjects With Stage III/ IV MelanomaUNC Lineberger Comprehensive Cancer CenterPhase 2 Completed25 enrolled 16 charts
NCT02833610 2026-02-18A Study of Denosumab in Multiple Myeloma Patients With Renal InsufficiencyMassachusetts General HospitalPhase 2 Completed55 enrolled
NCT03839459 2026-01-28Denosumab for Smoldering Multiple MyelomaUniversity of RochesterPhase 2 Completed20 enrolled 8 charts